47 results match your criteria: "Multicultural Dermatology Center[Affiliation]"
Dermatol Clin
January 2025
Henry W. Lim Division of Photomedicine and Photobiology, Department of Dermatology, Multicultural Dermatology Center, Henry Ford Health, 2799 West Grand Boulevard, Detroit, MI 48202, USA. Electronic address:
Vitiligo is a chronic skin condition characterized by the loss of melanocytes, resulting in white patches on the skin. While its exact cause is unknown, it's believed to be an autoimmune disorder involving genetic, environmental, and immunologic factors. Various treatments, including topical drugs, phototherapy, and surgery, exist, but further research is needed for more targeted therapies.
View Article and Find Full Text PDFJAMA Dermatol
October 2024
Department of Dermatology, Multicultural Dermatology Center, Henry Ford Health, Detroit, Michigan.
Importance: Defining meaningful improvement using the Total Vitiligo Area Scoring Index (T-VASI) and the Facial VASI (F-VASI) aids interpretation of findings from clinical trials evaluating vitiligo treatments; however, clear and clinically meaningful thresholds have not yet been established.
Objective: To assess concept validity and measurement performance of the T-VASI and F-VASI in patients with nonsegmental vitiligo and to identify meaningful change thresholds.
Design, Settings, And Participants: This mixed-methods study consisted of a secondary analysis of a phase 2 multicenter double-blind dose-ranging randomized clinical trial and embedded qualitative interviews conducted at 35 sites in Canada, France, Japan, and the US.
Lancet Public Health
June 2024
Department of Dermatology, EpiDermE, Henri Mondor Hospital, Université Paris-Est Créteil, Créteil, France; Department of Dermatology, Université Paris-Est Créteil Val de Marne-Université Paris, Paris, France. Electronic address:
Background: Vitiligo is a chronic autoimmune disease characterised by depigmented skin patches, which can pose substantial psychosocial challenges particularly in individuals with dark skin tones. Despite its impact on quality of life, there is an absence of standardised global epidemiological data. We sought to address this gap with the present study.
View Article and Find Full Text PDFBr J Dermatol
October 2023
The Multicultural Dermatology Center and The Henry W Lim, MD, Division of Photobiology and Photomedicine Unit, Department of Dermatology, Henry Ford Health, Detroit, MI, USA.
Int J Dermatol
March 2023
Multicultural Dermatology Center, Department of Dermatology, Henry Ford Hospital, Detroit, MI, USA.
Vitiligo is characterized by the development of depigmented macules and patches. Autoimmunity has been established as a factor in disease pathogenesis, leading to utilization of immunosuppressive agents. Topical immunosuppressants are commonly used; however, this treatment modality is often cumbersome and inefficient, as many patients have active disease with extensive body surface area involvement.
View Article and Find Full Text PDFClin Dermatol
June 2022
Multicultural Dermatology Center, Photomedicine Unit Unit, Department of Dermatology, Henry Ford Hospital, Detroit, Michigan, USA. Electronic address:
Recently, the authors of this study undertook a systematic review, and during the data collection phase, a systematic review was published on the same topic, despite not being registered on Prospective Registration of Systematic Reviews (PROSPERO). As a result we sought to perform an evidence-based review of the dermatology literature evaluating PROSPERO registration for published systematic reviews. Prospective systematic review protocol registration can help optimize resources, time, and the efforts of research teams rather than committing unplanned duplication.
View Article and Find Full Text PDFJAMA Dermatol
March 2021
Epidemiology in Dermatology and Evaluation of Therapeutics, Département Infectieux/Immuno/Vaccin, Paris-Est University, Paris Est Créteil University, Créteil, France.
Importance: Surgical interventions are a key part of the therapeutic arsenal, especially in refractory and stable vitiligo. Comparison of treatment outcomes between the different surgical procedures and their respective adverse effects has not been adequately studied.
Objective: To investigate the reported treatment response following different surgical modalities in patients with vitiligo.
J Am Acad Dermatol
May 2022
Department of Dermatology, University of California, San Francisco, California.
Background: Hidradenitis suppurativa (HS) is associated with comorbidities that contribute to poor health, impaired life quality, and mortality risk.
Objective: To provide evidence-based screening recommendations for comorbidities linked to HS.
Methods: Systematic reviews were performed to summarize evidence on the prevalence and incidence of 30 comorbidities in patients with HS relative to the general population.
F1000Res
September 2020
1. Multicultural Dermatology Center, Department of Dermatology, Henry Ford Health System, Detroit, MI, USA.
Hidradenitis suppurativa (HS) is a chronic, inflammatory, recurrent, and debilitating skin disease of the hair follicle unit that typically develops after puberty. HS has a significant negative impact on both the quality of life (QOL) of patients affected by this disease as well as family members and caregivers. However, the pathogenesis of HS is multifactorial and still remains to be fully elucidated, which makes the development of treatments difficult.
View Article and Find Full Text PDFJAAD Case Rep
July 2020
Multicultural Dermatology Center, Department of Dermatology, Henry Ford Health System, Detroit, Michigan.
Br J Dermatol
March 2019
Department of Dermatology, Hospital Henri Mondor, UPEC-Université Paris-Est Créteil, Paris, France.
Background: There is no cure or firm clinical recommendations for the treatment of vitiligo. One of the main issues is the heterogeneity of outcome measures used in randomized controlled trials for vitiligo.
Objectives: To define successful repigmentation from the patients' point of view and to propose how and when repigmentation should be evaluated in clinical trials in vitiligo.
J Cutan Med Surg
September 2018
1 Multicultural Dermatology Center, Department of Dermatology, Henry Ford Hospital, Detroit, MI, USA.
Background: Acne keloidalis nuchae (AKN) is a chronic scarring folliculitis with limited interventions of both high efficacy and low morbidity.
Objective: To assess the efficacy of the long-pulsed 1064-nm neodymium-doped yttrium-aluminum-garnet (Nd:YAG) laser and topical steroids as a treatment for AKN compared to topical steroids alone.
Methods: We conducted a single-blinded, randomised, within-patient right-left controlled trial (n = 13).
Cutis
October 2017
Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Skin of color (SOC) populations (ie, blacks, Hispanics, Asians) are at a notably higher risk for mortality from skin cancers such as melanoma than white individuals. In this article, we seek to answer the following question: Do knowledge-based interventions increase skin cancer awareness among SOC patients? Following an extensive literature search, a total of 4 articles were analyzed and discussed in this review.
View Article and Find Full Text PDFJ Dermatol Sci
February 2018
Department of Dermatology, Multicultural Dermatology Center, Henry Ford Hospital, Detroit, MI, USA. Electronic address:
J Am Acad Dermatol
August 2017
Department of Dermatology, Multicultural Dermatology Center, Henry Ford Hospital, Detroit, Michigan. Electronic address:
Background: Persistence of pigmentation after a melanocyte-keratinocyte transplantation procedure (MKTP) is an important consideration for efficacy.
Objective: We sought to determine long-term repigmentation of MKTP in vitiligo and other leukodermas.
Methods: A retrospective review of electronic medical records was conducted for all MKTPs performed at Henry Ford Hospital between January 2009 and April 2014.
J Am Acad Dermatol
July 2017
Multicultural Dermatology Center, Department of Dermatology, Henry Ford Hospital, Detroit, Michigan. Electronic address:
Background: There is a rationale for adding systemic photoprotective agents to the current photoprotection regimen.
Objective: This study was designed to objectively evaluate the molecular and photobiologic effects of oral administration of Polypodium leucotomos extract (PLE).
Methods: In all, 22 subjects with Fitzpatrick skin phototype I to III were enrolled.
Pigment Cell Melanoma Res
January 2017
Department of Dermatology and Pediatric Dermatology, Bordeaux University Hospitals, Bordeaux, France.
The Vitiligo Global Issues Consensus Conference (VGICC), through an international e-Delphi consensus, concluded that 'repigmentation' and 'maintenance of gained repigmentation' are essential core outcome measures in future vitiligo trials. This VGICC position paper addresses these core topics in two sections and includes an atlas depicting vitiligo repigmentation patterns and color match. The first section delineates mechanisms and characteristics of vitiligo repigmentation, and the second section summarizes the outcomes of international meeting discussions and two e-surveys on vitiligo repigmentation, which had been carried out over 3 yr.
View Article and Find Full Text PDFBr J Dermatol
April 2016
Multicultural Dermatology Center, Department of Dermatology, Henry Ford Hospital, New Center One, 3031 West Grand Blvd, Suite 800, Detroit, MI, 48202, U.S.A.
Background: Acne vulgaris is a common condition that occurs in all skin types. Postinflammatory hyperpigmentation (PIH) is often associated with acne in patients of darker skin types, making it a common complaint in dermatology offices. Despite this, there is limited understanding of and effective treatment options for PIH.
View Article and Find Full Text PDFDermatol Clin
January 2016
Department of Dermatology, Multicultural Dermatology Center, Henry Ford Hospital, Detroit, MI 48202, USA. Electronic address:
It is challenging to estimate a true prevalence of hidradenitis suppurativa (HS) because it is underdiagnosed and misdiagnosed. Prevalences have been reported from 0.00033% to 4.
View Article and Find Full Text PDFJ Am Acad Dermatol
November 2015
Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.
Br J Dermatol
April 2016
Multicultural Dermatology Center, Department of Dermatology, Henry Ford Hospital, 3031 W. Grand Blvd, Suite 800, Detroit, MI, 48202, U.S.A.
J Cutan Aesthet Surg
July 2015
Department of Dermatology, Multicultural Dermatology Center, Henry Ford Hospital, Detroit, Michigan, USA.
Vitiligo is an acquired skin disorder characterized by the destruction of melanocytes resulting in achromic macules and patches involving the affected skin. Multiple methods of treatments have emerged to manage vitiligo, including medical and surgical techniques. Among the surgical techniques described in the management of vitiligo are minipunch grafting, split-thickness skin grafting, hair follicle transplantation, suction blister grafting, and cultured and non-cultured autologous melanocyte transplantation.
View Article and Find Full Text PDFExp Dermatol
November 2015
Department of Dermatology, Multicultural Dermatology Center, Henry Ford Hospital, Detroit, MI, USA.
Br J Dermatol
June 2015
Multicultural Dermatology Center, Department of Dermatology, Henry Ford Hospital, Henry Ford Medical Center, New Center One, 3031 West Grand Blvd, Suite 800, Detroit, MI, 48202, U.S.A.
J Cutan Med Surg
September 2015
Multicultural Dermatology Center, Department of Dermatology, Henry Ford Hospital, Detroit, MINational Center for Vitiligo & Psoriasis, Riyadh, Saudi ArabiaShetty Nursing Home, Mumbai, India
Background: Patients with segmental vitiligo (SV), unlike those with nonsegmental vitiligo (NSV), have a more predictable course and are more responsive to surgery.
Objective: To report 10 patients with SV treated with the melanocyte-keratinocyte transplantation procedure (MKTP), who responded with unusual responses not previously reported in the literature.
Methods: This is a retrospective, observational study that reports 10 patients with SV who underwent the MKTP between May 2003 and May 2012.